|
Delayed
Nasdaq
14:05:20 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 0.1719 USD | +9.14% |
|
-1.32% | -90.50% |
| 09-01 | VivoSim Labs Plans To Develop Rat Liver Model To Complement NAMkind Human Liver Platform | CI |
| 08-12 | VivoSim Labs, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VIVS | Delayed | |
London S.E.
| 0R02 | Delayed | |
|
CBOE
| VIVS | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.227 | 0.468 | 0.6769 |
| Spread/Res. | -24.27% | -63.27% | -74.60% |
| Spread/Supp. | +9.56% | +9.56% | +9.56% |
| Support | 0.1569 | 0.1569 | 0.1569 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VIVS Stock
- Charts VivoSim Labs, Inc.
Select your edition
All financial news and data tailored to specific country editions
